Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Dennis J. Slamon, W. Eiermann, Nicholas J. Robert et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +17

Determination of subcutaneous tumor size in athymic (nude) mice

Mary M. Tomayko, C. Patrick Reynolds · Cancer Chemotherapy and Pharmacology · 1989 · 1.8K citations

Medicine, Cancer Biology, Oncology +6

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

Medicine, Nuclear Medicine, Radiology +15

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

Tore Lindmo, Epie Boven, Frank Cuttitta et al. · Journal of Immunological Methods · 1984 · 937 citations

Pharmacy, Immunology, Monoclonal Antibodies +13

Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line

Péter Nagy, Elza Friedländer, Minna Tanner et al. · Cancer Research · 2005 · 513 citations · Full text

Medicine, Cancer Biology, Molecular Biology +14